Search Page

1

Cite

Share

ADAMTS13 activity and the risk of thrombotic thrombocytopenic purpura relapse in pregnancy.

Raman R, Yang S, Wu HM, Cataland SR. Raman R, et al. Among authors: yang s. Br J Haematol. 2011 Apr;153(2):277-9. doi: 10.1111/j.1365-2141.2010.08558.x. Epub 2011 Jan 31. Br J Haematol. 2011. PMID: 21275971 No abstract available.

Cite

Share

2

Cite

Share

Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura.

Cataland SR, Yang SB, Witkoff L, Kraut EH, Lin S, George JN, Wu HM. Cataland SR, et al. Among authors: yang sb. Eur J Haematol. 2009 Dec 1;83(6):559-64. doi: 10.1111/j.1600-0609.2009.01331.x. Epub 2009 Aug 10. Eur J Haematol. 2009. PMID: 19674080

Cite

Share

3

Cite

Share

ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcome.

Yang S, Jin M, Lin S, Cataland S, Wu H. Yang S, et al. Haematologica. 2011 Oct;96(10):1521-7. doi: 10.3324/haematol.2011.042945. Epub 2011 May 23. Haematologica. 2011. PMID: 21606162 Free PMC article.

Cite

Share

4

Cite

Share

The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies.

Cataland SR, Yang S, Wu HM. Cataland SR, et al. Among authors: yang s. Br J Haematol. 2012 May;157(4):501-3. doi: 10.1111/j.1365-2141.2012.09032.x. Epub 2012 Feb 1. Br J Haematol. 2012. PMID: 22296585 No abstract available.

Cite

Share

5

Cite

Share

Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura.

Cataland SR, Peyvandi F, Mannucci PM, Lämmle B, Kremer Hovinga JA, Machin SJ, Scully M, Rock G, Gilbert JC, Yang S, Wu H, Jilma B, Knoebl P. Cataland SR, et al. Among authors: yang s. Am J Hematol. 2012 Apr;87(4):430-2. doi: 10.1002/ajh.23106. Epub 2012 Feb 24. Am J Hematol. 2012. PMID: 22367751 Clinical Trial. No abstract available.

Cite

Share

6

Cite

Share

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.

Lotta LA, Wu HM, Mackie IJ, Noris M, Veyradier A, Scully MA, Remuzzi G, Coppo P, Liesner R, Donadelli R, Loirat C, Gibbs RA, Horne A, Yang S, Garagiola I, Musallam KM, Peyvandi F. Lotta LA, et al. Among authors: yang s. Blood. 2012 Jul 12;120(2):440-8. doi: 10.1182/blood-2012-01-403113. Epub 2012 Apr 23. Blood. 2012. PMID: 22529288 Free PMC article.

Cite

Share

7

Cite

Share

Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.

Wu N, Liu J, Yang S, Kellett ET, Cataland SR, Li H, Wu HM. Wu N, et al. Among authors: yang s. Transfusion. 2015 Jan;55(1):18-24. doi: 10.1111/trf.12762. Epub 2014 Jun 23. Transfusion. 2015. PMID: 24953079

Cite

Share

8

Cite

Share

Clinical utility of complement biomarkers in the diagnosis and treatment of acute thrombotic microangiopathies.

Yui J, Holers VM, Yang S, Wu HM, Cataland SR. Yui J, et al. Among authors: yang s. Br J Haematol. 2014 Dec;167(5):697-8. doi: 10.1111/bjh.13025. Epub 2014 Jul 8. Br J Haematol. 2014. PMID: 25040791 No abstract available.

Cite

Share

9

Cite

Share

No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University Registry.

Masias C, Wu H, McGookey M, Jay L, Cataland S, Yang S. Masias C, et al. Among authors: yang s. Am J Hematol. 2018 Mar;93(3):E73-E75. doi: 10.1002/ajh.25002. Epub 2017 Dec 23. Am J Hematol. 2018. PMID: 29226481 No abstract available.

Cite

Share

10

Cite

Share

Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.

Wu H, Jay L, Lin S, Han C, Yang S, Cataland SR, Masias C. Wu H, et al. Among authors: yang s. Br J Haematol. 2020 Apr;189(1):e18-e20. doi: 10.1111/bjh.16415. Epub 2020 Feb 17. Br J Haematol. 2020. PMID: 32065383 No abstract available.

Cite

Share